Pawrents and their four-legged members are invited to the fourth annual ALX Dog Walk to strut their stuff. The 2-mile walk ...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article ...

As a kid growing up in Old Town, I was always curious about the historical markers placed throughout the neighborhood.

ALX Oncology announced promising results from the ASPEN-06 Phase 2 clinical trial of its CD47-blocker, evorpacept, at the 2025 ASCO Gastrointestinal Cancers Symposium. This investigational ...

ALX Oncology stock opened at $1.03 on Tuesday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 4.82 and a current ratio of 4.82. ALX Oncology has a 52 week low of $0.96 and a 52 ...

Fresh from a $105 million third-round financing earlier this month, ALX Oncology has won two FDA fast-track designations for its lead immuno-oncology drug. The Irish-American biotech picked up the ...

March 06, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology” or "the Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies that boost the immune system ...

ALX Oncology Holdings, Inc. (“ALX Oncology” or the “Company”), (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and ...